← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $1.0M of BioMarin Pharmaceutical Inc.

Sold$1,004,340
$83.70Price
12,000Shares
−2%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Wed, Dec 15. Filed Fri, Dec 17, 7:03 PM ET, after the close. Not investment advice.